Talk Presenting Companies (Theatre B) track
Ophthalmology: Hong Kong Haixi Pharmaceuticals Ltd
Mon, Nov 9, 2026 · 9:30–9:45 AM CET Koelnmesse
About this session
Haixi Pharmaceticals Co., Ltd is a HKEX-listed innovate pharmaceutical company. Founded in 2012, the company is headquartered in China with fully integrated activities in R&D, manufacturing, sales and marketing. Several products of the company are top-2 leaders in the Chinese market, generating profitable revenue. The company has a strong R&D pipeline of first-in-class innovative products in different stages of clinical development, e.g., HX9428 an orally bioavailable SM in Phase II trials for nAMD in both China and US, C019199 a SM in Phase III trial for recurrent osteosarcoma.
Speaker
-
President, R&D and Global Affairs · Hong Kong Haixi Pharmaceuticals Ltd
Speaker